Predictive Oncology Inc. Revenue 2017–2025
Predictive Oncology Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Predictive Oncology Inc. revenue for the quarter ending March 31, 2026 was 35311, a 67.99% decrease year-over-year.
- Predictive Oncology Inc. revenue for the twelve months ending March 31, 2026 was 151921, a 79.82% decrease year-over-year.
- Predictive Oncology Inc. annual revenue for 2025 was 125284, a 47.72% increase from 2024.
- Predictive Oncology Inc. annual revenue for 2024 was 84812, a 94.79% decrease from 2023.
- Predictive Oncology Inc. annual revenue for 2023 was 1.6 M, a 8.12% increase from 2022.
- Predictive Oncology Inc. annual revenue for 2022 was 1.5 M.
Predictive Oncology Inc. (AGPU) — Frequently Asked Questions
Predictive Oncology Inc. (AGPU) is a publicly traded US company. It has a market capitalization of $115M. In fiscal 2025 it reported revenue of $125,284 and net income of -$233M. Explore AGPU's stock price, financial statements, earnings history, margins and key ratios below.
What is Predictive Oncology Inc.'s market cap?
Predictive Oncology Inc. (AGPU) has a market capitalization of $115M.
What is the AGPU stock price?
AGPU trades at $6.62 (-2.22% on the day).
How much revenue does Predictive Oncology Inc. make?
Predictive Oncology Inc. reported revenue of $125,284 in fiscal 2025.
Is AGPU profitable?
In fiscal 2025, Predictive Oncology Inc. reported net income of -$233M.